Mito Red Light Super Mobile Recall Issued for Battery Fire Risk

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

MITO RED LIGHT INC is recalling the Mito Red Light, Super Mobile near-infrared therapy device due to a lithium-ion battery that may malfunction and catch fire.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on August 3, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

What Happened

MITO RED LIGHT INC has initiated a voluntary recall of the Mito Red Light, Super Mobile device. The near-infrared therapy device contains a lithium-ion battery that may malfunction, causing it to catch fire or burst into flames.

Which Products Are Affected

The recall involves the Mito Red Light, Super Mobile. All Serial/Lot numbers are affected (No UDI). The recall number is Z-2478-2026. Distribution includes US nationwide in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NL, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Australia, Canada, China, Japan, New Zealand, Spain, Switzerland, United Arab Emirates, United Kingdom.

What You Should Do

Consumers should stop using the recalled device. Contact MITO RED LIGHT INC for further information regarding the recall.

Why This Matters

The recall addresses a potential fire hazard from the device's lithium-ion battery in a product distributed nationwide and internationally.

Source

FDA recall Z-2478-2026 (Class II, Ongoing).

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
MITO RED LIGHT INC is recalling the Mito Red Light, Super Mobile near-infrared therapy device due to a lithium-ion battery that may malfunction and catch fire.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "high" severity. Take precautions and monitor for updates.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.